Skip to main content

Gupta Ashoo's Form 4 filing

4D Molecular Therapeutics, Inc. (FDMT) · filed Mar 24, 2026

Accession no.
0001193125-26-122341
Filed
Mar 24, 2026
Trade date
Mar 20, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.36K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gupta AshooCIK 0002091461Officer (VP, Finance and Controller)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 20, 2026Common StockMOption exerciseAcquired+865–F1–47,224Direct
Mar 20, 2026Common StockSSaleDisposed−310$8.61−$2,669.146,914Direct
Mar 20, 2026Common StockMOption exerciseAcquired+221–F1–47,135Direct
Mar 20, 2026Common StockSSaleDisposed−80$8.61−$688.847,055Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 20, 2026Common StockMOption exerciseDisposed−865$0.00$012,119Direct
Mar 20, 2026Common StockMOption exerciseDisposed−221$0.00$03,087Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted Stock Units convert into common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)